Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Brain Diseases, Metabolic (D001928)
Parent Node:
expand
Hypoxia-Ischemia, Brain (D020925)
Parent Node:
expand
Seizures (D012640)
..Starting node
..expand
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency (C566449)

       Child Nodes:



 Sister Nodes: 
..expandAdams Nance syndrome (C538224)
..expandAlcohol Withdrawal Seizures (D020270)
..expandAlopecia-Mental Retardation Syndrome with Convulsions and Hypergonadotropic Hypogonadism (C563370)
..expandBaraitser Rodeck Garner syndrome (C537906)
..expandCerebroretinal Microangiopathy with Calcifications and Cysts (C567401)
..expandChromosome 15q13.3 Microdeletion Syndrome (C567439)
..expandConvulsive Disorder, Familial, with Prenatal or Early Onset (C565678)
..expandCopper deficiency, familial benign (C535468)
..expandCryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly (C563840)
..expandDysmyelination With Jaundice (C565610)
..expandEPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11 (OMIM:613721)
..expandEPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12 (OMIM:613722)
..expandEPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5 (OMIM:613477)
..expandEPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7 (OMIM:613720)
..expandHyper-Beta-Alaninemia (C562684)
..expandHyperleucine-Isoleucinemia (C562674)
..expandHyperphosphatemia, Polyuria, and Seizures (C565494)
..expandHypoparathyroidism-retardation-dysmorphism syndrome (C537157)
..expandHypotonia, Seizures, And Precocious Puberty (C567566)
..expandInfantile convulsions and paroxysmal choreoathetosis, familial (C535522)
..expandMental retardation, keratoconus, febrile seizures, and sinoatrial block (C537452)
..expandMental retardation, X-linked, syndromic 5 (C535773)
..expandMethionine Malabsorption Syndrome (C562682)
..expandMicrocephaly seizures genital hypoplasia (C537540)
..expandMicrocephaly seizures mental retardation heart disorders (C537544)
..expandMicrocephaly sparse hair mental retardation seizures (C537545)
..expandMICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY (OMIM:613668)
..expandMICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY (OMIM:613402)
..expandMuller Barth Menger syndrome (C537370)
..expandPACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS (OMIM:600176)
..expandPartington X-linked mental retardation syndrome (C536300)
..expandPerniola Krajewska Carnevale syndrome (C536660)
..expandPhosphoglycerate Dehydrogenase Deficiency (C566618)
..expandPhosphoserine Aminotransferase Deficiency (C567032)
..expandPyridoxamine 5-Prime-Phosphate Oxidase Deficiency (C566449)
..expandQazi Markouizos syndrome (C536259)
..expandSeSAME syndrome (C557674)
..expandTranebjaerg Svejgaard syndrome (C536978)
..expandWarman Mulliken Hayward syndrome (C536684)
..expandX-linked mental retardation Gustavson type (C536759)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:9541
Name:Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
Definition:
Alternative IDs:OMIM:610090
ParentIDs:MESH:D001928|MESH:D012640|MESH:D020925
TreeNumbers:C10.228.140.163/C566449 |C10.228.140.300.150.716/C566449 |C10.228.140.490.631/C566449 |C10.228.140.624.500/C566449 |C10.597.742/C566449 |C14.907.253.092.716/C566449 |C18.452.132/C566449 |C23.888.592.742/C566449
Synonyms:Epileptic Encephalopathy, Neonatal, PNPO-Related |PNPO Deficiency |PNPO-Related Neonatal Epileptic Encephalopathy |Pyridoxal 5'-Phosphate-Dependent Epilepsy |Pyridoxine-5'-Phosphate Oxidase Deficiency |Seizures, Pyridoxine-Resistant, PLP-Sensitive
Slim Mappings:Cardiovascular disease|Metabolic disease|Nervous system disease|Signs and symptoms
Reference: MedGen: C566449
MeSH: C566449
OMIM: 610090;

Genes: PNPO;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:0000496Abnormality of eye movement
3 HP:0001903Anemia
4 HP:0003785Decreased CSF homovanillic acid
5 HP:0001298Encephalopathy
6 HP:0001508Failure to thrive
7 HP:0008872Feeding difficulties in infancy
8 HP:0001263Global developmental delay
9 HP:0001276Hypertonia
10 HP:0001943Hypoglycemia
11 HP:0002151Increased serum lactate
12 HP:0001942Metabolic acidosis
13 HP:0008936Muscular hypotonia of the trunk
14 HP:0001336Myoclonus
15 HP:0001622Premature birth
16 HP:0000253Progressive microcephaly
17 HP:0001250Seizure
18 HP:0002317Unsteady gait
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_018129.3(PNPO):c.364_417del5455163PNPOPathogenic774710082RCV000006897; NMedGen:C1864723,OMIM:610090,ORPHA:79096174602292446022924NM_018129.3:c.364_417del54NC_000017.10:g.46022924G>AOMIM Allelic Variant:603287.0002C1864723 610090 Pyridoxal 5'-phosphate-dependent epilepsy
NM_018129.3(PNPO):c.448_451delCCTG (p.Pro150Argfs)55163PNPOLikely pathogenic;Pathogenic796052872RCV000194659; RCV000188508; NMedGen:C1864723,OMIM:610090,ORPHA:79096; MedGen:CN221809174602325746023260NM_018129.3:c.448_451delCCTGNP_060599.1:p.Pro150ArgfsNC_000017.10:g.46023257_46023260delCCTG-CN221809 not provided; C1864723 610090 Pyridoxal 5'-phosphate-dependent epilepsy
NM_018129.3(PNPO):c.520C>T (p.Gln174Ter)55163PNPOPathogenic267606958RCV000006899; NMedGen:C1864723,OMIM:610090,ORPHA:79096174602332946023329NM_018129.3:c.520C>TNP_060599.1:p.Gln174TerNC_000017.10:g.46023329C>TOMIM Allelic Variant:603287.0004C1864723 610090 Pyridoxal 5'-phosphate-dependent epilepsy
NM_018129.3(PNPO):c.674G>A (p.Arg225His)55163PNPOPathogenic550423482RCV000208779; NMedGen:C1864723,OMIM:610090,ORPHA:79096174602403646024036NM_018129.3:c.674G>ANP_060599.1:p.Arg225HisOMIM Allelic Variant:603287.0005C1864723 610090 Pyridoxal 5'-phosphate-dependent epilepsy
NM_018129.3(PNPO):c.685C>T (p.Arg229Trp)55163PNPOPathogenic104894629RCV000006896; NMedGen:C1864723,OMIM:610090,ORPHA:79096174602404746024047NM_018129.3:c.685C>TNP_060599.1:p.Arg229TrpNC_000017.10:g.46024047C>TOMIM Allelic Variant:603287.0001C1864723 610090 Pyridoxal 5'-phosphate-dependent epilepsy
NM_018129.3(PNPO):c.686G>A (p.Arg229Gln)55163PNPOPathogenic773450573RCV000208780; RCV000188500; NMedGen:C1864723,OMIM:610090,ORPHA:79096; MedGen:CN221809174602404846024048NM_018129.3:c.686G>ANP_060599.1:p.Arg229GlnNC_000017.10:g.46024048G>AOMIM Allelic Variant:603287.0006CN221809 not provided; C1864723 610090 Pyridoxal 5'-phosphate-dependent epilepsy
NM_018129.3(PNPO):c.784T>C (p.Ter262Gln)55163PNPOPathogenic104894631RCV000006898; NMedGen:C1864723,OMIM:610090,ORPHA:79096174602414646024146NM_018129.3:c.784T>CNP_060599.1:p.Ter262GlnNC_000017.10:g.46024146T>COMIM Allelic Variant:603287.0003C1864723 610090 Pyridoxal 5'-phosphate-dependent epilepsy